The marginal costs associated with earlier start of ART might be significant, especially in areas that historically have had limited HIV infrastructure, although these areas may reap the greatest benefits from timely access to ART.
← all excerpts
Assessing the Benefits of Rapid Start Antiretroviral Therapy for Newly Diagnosed People with HIV in the United States.
1
—
—